An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: A per-protocol and completers analysis

BACKGROUND: The distinct pharmacological properties and clinical uses of extended-release naltrexone (XR-NTX) and sublingual buprenorphine-naloxone (BUP-NX) present challenges in analyzing patient outcomes. METHODS: We conducted a secondary analysis of a multi-site randomized trial comparing XR-NTX...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Alcohol Depend
Hlavní autoři: Mitchell, Mary M., Schwartz, Robert P., Choo, Tse-Hwei, Pavlicova, Martina, O’Grady, Kevin E., Gryczynski, Jan, Stitzer, Maxine L., Nunes, Edward V., Rotrosen, John
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8034542/
https://ncbi.nlm.nih.gov/pubmed/33352487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2020.108422
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky